Kinnos

Kinnos

Pioneering color technology to revolutionize how we use disinfectants.

Founded 2014 20 employees Series B Total: $22.75M Biotechnology, Health Care

Kinnos is a New York-based startup that has been making waves in the biotechnology and health care industries since its establishment in 2014. The company's innovative approach revolves around pioneering color technology to revolutionize the use of disinfectants. Their flagship product, Highlight, has garnered accolades for its patented and award-winning technology, which has seen widespread adoption by first responders, healthcare systems, and transit agencies. The most recent milestone for Kinnos came in the form of a significant $15.00M Series B investment on May 2, 2023. This round of funding drew support from an impressive cohort of investors, including the Partnership Fund for New York City, Pioneer Healthcare Partners, Walgreens Boots Alliance, and the Kapor Center for Social Impact. Kinnos' breakthrough approach not only presents great potential for financial returns but also addresses critical needs within the healthcare and public health sectors. With its innovative technology already making a significant impact, the company's strong investor backing further solidifies its position as a promising player in the fight against the spread of infectious diseases.

Funding Stage	Amount	Investors	Lead Investors	Date
Series B	$15.00M	4	Pioneer Healthcare Partners, Walgreens Boots Alliance +2	02 May 2023
Series A	$6.00M	6	Golden Seeds, Meda Angels +4	05 Mar 2020
Seed Round	Undisclosed	-		01 Mar 2020
Seed Round	$1.00M	-		27 Feb 2017
Grant	$750.00K	-		11 Feb 2015

Funding Stage

Amount

Investors

Lead Investors

Date

Series B

$15.00M

Pioneer Healthcare Partners, Walgreens Boots Alliance +2

02 May 2023

Series A

$6.00M

Golden Seeds, Meda Angels +4

05 Mar 2020

Seed Round

Undisclosed

01 Mar 2020

Seed Round

$1.00M

27 Feb 2017

Grant

$750.00K

11 Feb 2015

FAQ About Kinnos

Pioneering color technology to revolutionize how we use disinfectants.

Kinnos was founded in 2014.

Kinnos operates in Biotechnology and Health Care. Its work centres on color technology, disinfectants, first responders and transit agencies.

Kinnos has approximately 20 employees.

Kinnos has completed 5 funding rounds, raising a total of $22.75M. The latest funding stage is Series B.

Top alternatives and competitors to Kinnos include Klonbiyotek, CellScape, HilleVax, Caligenix®, Achira Labs Pvt. Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Kinnos and Klonbiyotek are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Kinnos

Funding Rounds & Investors (5)

Kinnos Alternatives & Competitors

FAQ About Kinnos